APAC Clinical Trials in COVID-19 Pandemic-Best Practices and Expectations for Continuity in Global Drug Development

This article talks about the best practices adopted by Covance APAC during COVID-19 pandemic - The path for recovery was not trivial - it required innovative problem solving and the coordinated efforts of cross-functional teams. Learn about the steps the Covance APAC teams took to: ensure continuity of drug development; set sponsors' expectations for trial readiness in APAC; and develop best practices for a recovery model, which could be implemented beyond APAC to support global trials in the US and EU.

Copy and paste this URL:

https://drugdevelopment.labcorp.com/latest-thinking/explore-library/detail.html/covance/assetLibrary/articles/APAC-COVID19-Best-Practices-ARTCDS040.pdf